A pooled analysis of dietary long-chain omega-3 fatty acid intake and endometrial cancer risk

膳食长链 omega-3 脂肪酸摄入量与子宫内膜癌风险的汇总分析

基本信息

  • 批准号:
    9376490
  • 负责人:
  • 金额:
    $ 7.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2017
  • 资助国家:
    美国
  • 起止时间:
    2017-08-01 至 2019-07-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT Endometrial cancer is the most common gynecologic malignancy in the United States and the fourth most common cancer diagnosed in women. Incidence of the disease is rising, especially among black women who tend to be diagnosed with aggressive disease and who have a disproportionally higher mortality rate. Coupled with very low research funding on a per case and per death basis relative to other female cancers, and with few modifiable risk factors for disease prevention, there is a critical need to better understand endometrial cancer etiology, with special attention to racial disparities. There is increasing evidence that inflammation is an important driver of endometrial carcinogenesis. Long- chain omega-3 polyunsaturated fatty acids (LCn3PUFA) are anti-inflammatory and have been shown by us to reduce endometrial cancer risk. However, we have reported differences in these associations by body mass and tumor histology. No study has been able to examine whether the association between diets high in LCn3PUFA and endometrial cancer risk differs between black and white women. In order to reveal reliable estimates of association and to identify subgroups of women that stand to benefit the most from diets rich in LCn3PUFA, a very large study is needed. We propose to examine the association of dietary LCn3PUFA with endometrial cancer and its subtypes and to examine possible heterogeneity of these associations by race and body mass, by pooling dietary data in the Epidemiology of Endometrial Cancer Consortium of studies. This secondary analysis will include 19 participating studies, 10,117 endometrial cancer cases and 26,881 controls, and will provide high statistical power and precision to examine these research questions. The proposed work will have a significant impact on endometrial cancer prevention by informing clinicians, patients, and nutrition scientists as to whether and for whom an LCn3PUFA-rich diet may be of benefit. Results from this investigation will inform a larger NIH grant application to conduct a chemoprevention trial that will aim to examine whether LCn3PUFA supplementation increases LCn3PUFA concentrations and causes a reduction in biomarkers of inflammation in endometrial tissues of women diagnosed with endometrial cancer. Our long-term goal is to reduce incidence among high- risk women, such as those diagnosed with endometrial hyperplasia, and to reduce recurrence among endometrial cancer survivors.
摘要

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Theodore M. Brasky其他文献

Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.
患有和未患有癌症的女性与抗高血压药物使用相关的心血管结局:女性健康倡议的结果。
  • DOI:
    10.1634/theoncologist.2019-0977
  • 发表时间:
    2020
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. Reding;A. Aragaki;Richard K. Cheng;A. Barac;S. Wassertheil;Jessica Chubak;Marian C. Limacher;W. Hundley;R. D’Agostino;Mara Z. Vitolins;Theodore M. Brasky;L. Habel;Eric J. Chow;R. Jackson;Chu Chen;A. Morgenroth;Wendy E. Barrington;M. Banegas;M. Barnhart;R. Chlebowski
  • 通讯作者:
    R. Chlebowski
Associations of Cancer Patients' Demographic and Clinical Characteristics With Cannabis-Related Interest and Behaviors.
癌症患者的人口统计和临床特征与大麻相关兴趣和行为的关联。
  • DOI:
    10.1089/jpm.2023.0490
  • 发表时间:
    2023
  • 期刊:
  • 影响因子:
    2.8
  • 作者:
    N. Adley;Theodore M. Brasky;Sara R. Conroy;Alison M Newton;Jesse J. Plascak;S. Strassels;John L Hays;J. Krok
  • 通讯作者:
    J. Krok
Prevalence of cannabis and medication use by indices of residential urbanicity and deprivation among Ohio cancer patients
  • DOI:
    10.1007/s10552-025-01972-x
  • 发表时间:
    2025-02-12
  • 期刊:
  • 影响因子:
    2.100
  • 作者:
    Theodore M. Brasky;Shieun Lee;Bella McBride;Alison M. Newton;Ryan D. Baltic;Theodore L. Wagener;Sara Conroy;John L. Hays;Erin E. Stevens;Anita Adib;Jessica L. Krok-Schoen
  • 通讯作者:
    Jessica L. Krok-Schoen

Theodore M. Brasky的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Theodore M. Brasky', 18)}}的其他基金

Electronic cigarette use in lung cancer patients
肺癌患者使用电子烟
  • 批准号:
    10768042
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
Electronic cigarette use in lung cancer patients
肺癌患者使用电子烟
  • 批准号:
    10087897
  • 财政年份:
    2018
  • 资助金额:
    $ 7.75万
  • 项目类别:

相似海外基金

Development of Enhanced Anti-inflammatory Blood Mononuclear Cell Therapy for ARDS and Elucidation of the Molecular Mechanism
ARDS增强抗炎血液单核细胞治疗的进展及分子机制的阐明
  • 批准号:
    23K07659
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Exploring therapeutic effects of anti-inflammatory and resolving factors in osteoporosis model mice
探讨抗炎和缓解因子对骨质疏松模型小鼠的治疗作用
  • 批准号:
    23K15705
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Investigation of the relation between age-related estradiol fluctuation and pro-/anti-inflammatory effects in transplant immune response.
研究年龄相关雌二醇波动与移植免疫反应中促/抗炎作用之间的关系。
  • 批准号:
    23K19490
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Non-coating anti-microbial, anti-host protein deposition, anti-inflammatory urinary catheter
无涂层抗菌、抗宿主蛋白沉积、抗炎导尿管
  • 批准号:
    10697567
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
Identification and optimization of verapamil as a novel neuroprotective and anti-inflammatory agent for reducing long-term neurological morbidities following organophosphate-induced status epilepticus
维拉帕米作为新型神经保护和抗炎剂的鉴定和优化,用于减少有机磷引起的癫痫持续状态后的长期神经系统发病率
  • 批准号:
    10727765
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
Elucidation of anti-inflammatory mechanism of surface layer protein of lactic acid bacteria focusing on its interaction with lipopolysaccharide.
阐明乳酸菌表面层蛋白的抗炎机制,重点关注其与脂多糖的相互作用。
  • 批准号:
    23K13905
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Anti-inflammatory Effects of Hydrogen Gas Produced by Gut Microflora in a Mouse Model of ARDS
肠道菌群产生的氢气对 ARDS 小鼠模型的抗炎作用
  • 批准号:
    23K08467
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Knockdown of AdipoR2 Compromises Adiponectin’s Anti-inflammatory Actions by Mainly Promoting a Pro-inflammatory Chemokine and Cytokine Secretory Profile in THP-1 Macrophages
AdipoR2 的敲低主要通过促进 THP-1 巨噬细胞中促炎趋化因子和细胞因子的分泌特征来损害脂联素的抗炎作用
  • 批准号:
    493138
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
SBIR Phase I: Structure-guided design of anti-inflammatory modulators of protease-activated receptor 1 (PAR1)
SBIR I 期:蛋白酶激活受体 1 (PAR1) 抗炎调节剂的结构引导设计
  • 批准号:
    2223225
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
    Standard Grant
Targeting anti-viral and anti-inflammatory responses during ocular HSV-1 infection to prevent vision impairment.
针对眼部 HSV-1 感染期间的抗病毒和抗炎反应,以预防视力障碍。
  • 批准号:
    10651054
  • 财政年份:
    2023
  • 资助金额:
    $ 7.75万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了